Autologous Transplantation for Multiple Myeloma in the Era of New Drugs: A Phase III Study of the Intergroupe Francophone Du Myelome (IFM/DFCI 2009 Trial)

被引：1

作者：

Attal, Michel ^{[1
]}

Lauwers-Cances, Valerie ^{[2
]}

Hulin, Cyrille ^{[3
]}

Facon, Thierry ^{[4
]}

Caillot, Denis ^{[5
]}

Escoffre, Martine ^{[6
]}

Arnulf, Bertrand ^{[7
]}

Macro, Margaret ^{[8
]}

Belhadj, Karim ^{[9
]}

Garderet, Laurent ^{[10
]}

Roussel, Murielle ^{[11
,12
]}

Mathiot, Claire ^{[13
]}

Avet-Loiseau, Herve ^{[1
]}

Munshi, Nikhil C. ^{[14
,15
]}

Richardson, Paul G. ^{[16
]}

Anderson, Kenneth C. ^{[17
]}

Harousseau, Jean Luc ^{[18
]}

Moreau, Philippe ^{[19
]}

机构：

[1] Inst Univ Canc Toulouse Oncopole, Toulouse, France

[2] CHU Toulouse, Toulouse, France

[3] CHRU Hop Brabois, Nancy, France

[4] CHRU Lille, Hop Claude Huriez, Malad Sang, F-59037 Lille, France

[5] Hop Bocage, Dijon, France

[6] CHU Rennes, Rennes, France

[7] Hop St Louis, Paris, France

[8] CHU Caen, F-14000 Caen, France

[9] CHU Henri Mondor, F-94010 Creteil, France

[10] Hop St Antoine, F-75571 Paris, France

[11] Inst Univ Canc, Toulouse, France

[12] Univ Hosp, Dept Hematol, Toulouse, France

[13] IFM, Paris, France

[14] Harvard Univ, Sch Med, Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA

[15] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA

[16] Harvard Univ, Sch Med, Dana Farber Canc Inst,Div Hematol Malignancy, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA 02115 USA

[17] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA

[18] HAS, Paris, France

[19] Nantes Univ Hosp, Dept Hematol, Nantes, France

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[31] Bone marrow versus blood as source of hematopoietic stem cells after high dose therapy in multiple myeloma: A prospective, randomized study of the ''Intergroupe Francais du Myelome'' (IFM)
Harousseau, JL
Attal, M
Payen, C
Facon, T
Michaux, JL
Guilhot, F
Moconduit, M
Fuzibet, JG
Caillot, D
Dorvaux, V
Cahn, JY
Grobois, B
Stoppa, AM
Ifrah, N
Sotto, JJ
Pignon, B
Bataille, R
BLOOD, 1997, 90 (10) : 1018 - 1018
[32] Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myelome
Royer, Bruno
Minvielle, Stephane
Diouf, Momar
Roussel, Murielle
Karlin, Lionel
Hulin, Cyrille
Arnulf, Bertrand
Macro, Margaret
Cailleres, Sylvie
Brion, Annie
Brechignac, Sabine
Belhadj, Karim
Chretien, Marie Lorraine
Wetterwald, Marc
Chaleteix, Carine
Tiab, Mourad
Leleu, Xavier
Frenzel, Laurent
Garderet, Laurent
Choquet, Sylvain
Fuzibet, Jean Gabriel
Dauriac, Charles
Fornecker, Luc-Matthieu
Benboubker, Lotfi
Facon, Thierry
Moreau, Philippe
Avet-Loiseau, Herve
Marolleau, Jean Pierre
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (18) : 2125 - +
[33] Twice Weekly Induction with Ixazomib-Lenalidomide-Dexamethasone (IRd) Combination Followed By Extended IRD Consolidation and Lenalidomide Maintenance in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Phase 2 Study from the Intergroupe Francophone Du Myelome (IFM 2014-03)
Roussel, Murielle
Hebraud, Benjamin
Hulin, Cyrille
Leleu, Xavier
Facon, Thierry
Boyle, Eileen
Touzeau, Cyrille
Pegourie, Brigitte
Perrot, Aurore
Stoppa, Anne-Marie
Marolleau, Jean-Pierre
Moreau, Philippe
Avet-Loiseau, Herve
Devlamynck, Laure
Lauwers-Cances, Valerie
Attal, Michel
BLOOD, 2019, 134
[34] Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients:: A study of the intergroupe francophone du myelome
Decaux, Olivier
Lode, Laurence
Magrangeas, Florence
Charbonnel, Catherine
Gouraud, Wilfried
Jezequel, Pascal
Attal, Michel
Harousseau, Jean-Luc
Moreau, Philippe
Bataille, Regis
Campion, Loic
Avert-Loiseau, Herve
Minvielle, Stephane
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) : 4798 - 4805
[35] Treatment of Myeloma Cast Nephropathy (MCN): A Randomized Trial Comparing Intensive Haemodialysis (HD) with High Cut-Off (HCO) or Standard High-Flux Dialyzer in Patients Receiving a Bortezomib-Based Regimen (the MYRE Study, by the Intergroupe Francophone du Myelome (IFM) and the French Society of Nephrology (SFNDT))
Bridoux, Frank
Pegourie, Brigitte
Augeul-Meunier, Karine
Royer, Bruno
Joly, Bertrand
Lamy, Thierry
Kolb, Brigitte
Benboubker, Lofti
Arnulf, Bertrand
Jaccard, Arnaud
Chevret, Sylvie
Fermand, Jean-Paul
BLOOD, 2016, 128 (22)
[36] Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
Mellqvist, Ulf-Henrik
Gimsing, Peter
Hjertner, Oyvind
Lenhoff, Stig
Laane, Edward
Remes, Kari
Steingrimsdottir, Hlif
Abildgaard, Niels
Ahlberg, Lucia
Blimark, Cecilie
Dahl, Inger Marie
Forsberg, Karin
Gedde-Dahl, Tobias
Gregersen, Henrik
Gruber, Astrid
Guldbrandsen, Nina
Haukas, Einar
Carlson, Kristina
Kvam, Ann Kristin
Nahi, Hareth
Lindas, Roald
Andersen, Niels Frost
Turesson, Ingemar
Waage, Anders
Westin, Jan
BLOOD, 2013, 121 (23) : 4647 - 4654
[37] Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)
M Mohty
M Attal
G Marit
C E Bulabois
F Garban
N Gratecos
B Rio
J P Vernant
J J Sotto
J Y Cahn
D Blaise
J P Jouet
T Facon
I Yakoub-Agha
Bone Marrow Transplantation, 2005, 35 : 165 - 169
[38] Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study
Harousseau, Jean-Luc
Attal, Michel
Leleu, Xavier
Troncy, Jacques
Pegourie, Brigitte
Stoppa, Anne-Marie
Hulin, Cyrille
Benboubker, Lofti
Fuzibet, Jean-Gabriel
Renaud, Marc
Moreau, Philippe
Avet-Loiseau, Herve
HAEMATOLOGICA, 2006, 91 (11) : 1498 - 1505
[39] Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: Premilinary results of an IFM phase II study
Harousseau, JL
Attal, M
Coiteux, V
Stoppa, AM
Hulin, C
Benboubker, L
Fuzibet, JG
Renard, M
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 598S - 598S
[40] A New Prognostic Scoring System for Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma
Ozaki, Shuji
Saitoh, Takayuki
Handa, Hiroshi
Suzuki, Kenshi
Takezako, Naoki
Sunami, Kazutaka
Kuroda, Yoshiaki
Itagaki, Mitsuhiro
Asaoku, Hideki
Nagura, Eiichi
Kazuyuki, Shimizu
Murakami, Hirokazu
BLOOD, 2016, 128 (22)

← 1 2 3 4 5 →